Investing in tomorrow's healthcare

What is angel investing?

Angel investing can be both enjoyable and rewarding

A Business Angel Investor uses their personal disposable income, finance and business or professional experience to invest in the growth of a small business, generally in start-up or early stage. Angel investors can make investments on their own or as part of a group (syndicate). Whilst early stage investing is high risk, it can also be enjoyable and rewarding with the opportunity to not only add value through an investment, but also though experience and expertise.

For further information generally on angel investing please see:


The Angels in MedCity Initiative

The United Kingdom is home to some of the most established and renowned institutions with world leading medical technology innovations. It has one of the world’s fastest growing medtech clusters, with hundreds of early stage companies now based in the London – Oxford – Cambridge triangle. One of the biggest constraints to allowing many of these early stage companies to exploit their true growth potential is access to capital (both financial capital and human capital).

The Angels in MedCity initiative aims to provide individuals working within the various financial institutions in the city of London with the wherewithal and knowledge to be able to make early stage investments in early stage medtech companies through a series of investor workshops and entrepreneur pitching events.

The initiative aims to lend a helping hand to the emerging medtech community and help position the Golden Triangle as a world leading, interconnected region for life sciences research, development, manufacturing, and commercialisation.

Learn more about being an angel investor 


Become an Angels in MedCity investor

Become an investor >


Become an Angels in MedCity entrepreneur

Entrepreneurs >


On Twitter

RT @joreis13: Thank you to all the investors that attended @AngelsInMedCity pitching event last night @TheCrick! Stay tuned for our next ev…
7 hours 55 min ago
RT @Neelam_P1: Last panel chaired by Sarah Haywood @MedCityHQ discussing the difficult topic of pricing a digital therapeutic. @DHealthLDN
11 hours 52 min ago